CBD Provider CV Sciences Applies to NASDAQ

New Cannabis Ventures
By NCV NewswireJul 23, 2018, 9:03 am66 pts
CV Sciences, Inc. Files Application for Up-Listing to the NASDAQ Capital Market LAS VEGAS, July 23, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including cannabidiol (CBD) oil and developer of specialty pharmaceutical…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Hemp Needs What Alcohol Already Has: A Clear Definition (Op-Ed) 73

Ted Cruz Explains His Vote To Keep Hemp THC Products Federally Legal In Historic First Senate Roll Call On Cannabis 70

Missouri Officials Propose Tightening Cannabis Licensing Rules 55

‘They’re lying’: deal to reopen government could doom hemp 39

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.